Until about 15 years ago, most men diagnosed with prostate cancer — no matter how aggressive — underwent surgery or radiation ...
For example, androgens attach to special receptors on the surface of prostate cancer cells, which enables the cells to send ...
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...
Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...
Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...
Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...
Rochester’s Terrance Anthony Grimes is one of nearly 17,000 men diagnosed with prostate cancer in New York each year. But ...
Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designed to use prostate cancer biopsy tissue to help physicians ...
If you’ve been diagnosed with advanced prostate cancer, there’s a good chance you’ll receive androgen deprivation therapy (ADT) at some point, as ADT is a mainstay of prostate cancer treatment. It ...
Former U.S. President Joe Biden’s recent cancer diagnosis brought widespread attention to what is known as the “Gleason score,” a grading system used to assess the prognosis of men with prostate ...
Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and blood in the urine. Some of these conditions can also cause elevated prostate ...